Download - 24.antiplatelet drugs
Transcript
Classification1. TXA2 synthesis inhibitor: Aspirin
2. Others: Dipyridamole, clopidogrel, ticlopidine
abciximab
ASPIRIN
Low dose aspirin (75-150 mg/day)- selectively produce antiplatelet activity
Irreversibly inhibits thromboxane synthase
Reduces TXA2 production antiplatelet activity
Mechanism of action Membrane phospholipids ↓Arachidonic acid ↓cyclic endoperoxides ↓ Thromboxane synthase TXA2 (platelet aggregation)
AspirinInhibits
Therapeutic uses1. Myocardial infarction (MI)2. Prevent MI in high risk patients3. Reduce incidence of stroke in high risk patients